India risks becoming "unhealthier before it becomes richer," CEA V Anantha Nageswaran warnsIndia faces a health challenge before achieving wealth. Chief Economic Advisor V Anantha Nageswaran points to rising obesity and sedentary ...
14 Jun, 2026, 05.29 PM IST
The supplement your doctor hasn't mentioned yet could be quietly fighting type 2 diabetes - here's everything you need to knowFish oil benefits for type 2 diabetes: Fish oil supplementation reduced insulin resistance and improved glucose tolerance in non-obese diab...
01 Jun, 2026, 08.50 PM IST
'Don't eat idli, dosa or poha in breakfast if...': Doctor explains who should avoid them and what modern lifestyles requireA homeopathy physician suggests traditional Indian breakfasts like idli and dosa may not be ideal for sedentary individuals. He advocates f...
31 May, 2026, 08.53 PM IST
Artificial sweeteners may alter gut health and metabolism across generations, new study suggestsNew research suggests artificial sweeteners like sucralose and stevia could alter gut bacteria and metabolism. These changes may persist ac...
07 May, 2026, 11.49 AM IST
The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
05 May, 2026, 05.35 PM IST
Harvard-trained doctor lists 8 daily habits for stronger bones, a healthier heart and sharper brain between 24–45Dr Saurabh Sethi, a Harvard-trained doctor, highlights crucial daily habits for adults aged 25 to 45. These habits build a strong foundatio...
04 May, 2026, 09.32 AM IST
At 39, he was 147 kgs. At 42, he reversed diabetes. Man shares 5 lifestyle and diet changes that dropped his weight to 80 kgsSumit Agarwal’s story shared by Humans of Bombay shows how he went from weighing 147 kg at 39 and being diagnosed with Type 2 diabetes to r...
22 Apr, 2026, 04.47 PM IST
Novo Nordisk to phase out key drug, insulin cos spot big biz opportunityNovo Nordisk is set to discontinue some forms of its Mixtard insulin, including pen and cartridge versions, in India, coinciding with the a...
23 Apr, 2025, 09.20 AM IST
No more painful insulin shots: Hyderabad company develops oral insulin spray for diabetesHyderabad-based NiedlFree Technologies has developed a needle-free oral insulin spray called Ozulin, offering a painless alternative for di...
02 Nov, 2023, 12.51 PM IST
Biocon Biologics' arm gets USD 90 mn contract from Malaysian government for supply of insulinsBiocon Biologics, a part of Biocon Ltd, has created a Centre of Excellence (CoE) for insulins in Malaysia with end-to-end capabilities to m...
26 Apr, 2022, 10.37 AM IST
Biocon Biologics' biosimilar human insulin gets backing from EMA expert panelThe EMA's Committee for Medicinal Products for Human Use (CHMP) opinion will be considered by the European Commission. "The European Commis...
01 Apr, 2022, 10.03 AM IST
Eris enters JV with MJ Pharma to commercialise insulins in domestic marketThe business of the joint venture will be kickstarted with the launch of human insulin in the fourth quarter of FY22.
03 Dec, 2021, 07.55 PM IST
Biocon to reduce insulin prices to 10 cents per dayKiran Mazumdar Shaw, chairperson and managing director, Biocon said accessibility of insulin has been a major concern over the years due to...
26 Sep, 2019, 05.49 PM IST
Biocon links with Mexico's PiSA to tap US insulin marketBiocon said it has entered into a co-development and commercialization alliance with PiSA of Mexico for recombinant human insulin aimed at ...
17 Mar, 2016, 04.40 PM IST
National Pharmaceutical Pricing Authority exempts price controls for 3 insulins of WockhardtNPPA has exempted drug maker Wockhardt’s three insulin products from price controls for five years, starting January 8, 2015.
24 Nov, 2015, 12.59 AM IST
- NPPA asked to revisit decision on prices for insulin: Srikant Kumar Jena
The DoP has asked NPPA to revisit the decision of fixing ceiling prices of various insulin formulations in the wake of review applications ...
02 May, 2013, 06.21 PM IST
- Wockhardt plans to restart production of human insulin
Wockhardt is planning to restart production of human recombinant insulin Wosulin (50:50), for which the State Food and Drug Administration ...
24 Feb, 2007, 04.26 AM IST